[go: up one dir, main page]

MX9200532A - Agente farmaceuticos. - Google Patents

Agente farmaceuticos.

Info

Publication number
MX9200532A
MX9200532A MX9200532A MX9200532A MX9200532A MX 9200532 A MX9200532 A MX 9200532A MX 9200532 A MX9200532 A MX 9200532A MX 9200532 A MX9200532 A MX 9200532A MX 9200532 A MX9200532 A MX 9200532A
Authority
MX
Mexico
Prior art keywords
pharmaceutical agent
pharmaceutical
agent
Prior art date
Application number
MX9200532A
Other languages
English (en)
Inventor
Barker Alan Charles
Pearce Robert James
Robert David Anthony
Russell Simon Thomas
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of MX9200532A publication Critical patent/MX9200532A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX9200532A 1991-02-08 1992-02-07 Agente farmaceuticos. MX9200532A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102727A GB9102727D0 (en) 1991-02-08 1991-02-08 Pharmaceutical agent

Publications (1)

Publication Number Publication Date
MX9200532A true MX9200532A (es) 1992-08-01

Family

ID=10689748

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200532A MX9200532A (es) 1991-02-08 1992-02-07 Agente farmaceuticos.

Country Status (12)

Country Link
CN (1) CN1064809A (es)
AP (1) AP9200355A0 (es)
AU (1) AU1189392A (es)
CA (1) CA2060825A1 (es)
GB (2) GB9102727D0 (es)
HU (1) HUT60489A (es)
IE (1) IE920243A1 (es)
IL (1) IL100793A0 (es)
MX (1) MX9200532A (es)
PT (1) PT100097A (es)
WO (1) WO1992013853A1 (es)
ZA (1) ZA92729B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW297025B (es) * 1992-02-14 1997-02-01 Squibb & Sons Inc
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
DK3046584T3 (en) 2013-09-16 2017-10-02 Astrazeneca Ab THERAPEUTIC POLYMER NANOPARTICLES AND PROCEDURES FOR PREPARING AND USING THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
ATE117294T1 (de) * 1989-08-11 1995-02-15 Ici Plc Chinolin-derivate, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.

Also Published As

Publication number Publication date
CN1064809A (zh) 1992-09-30
IE920243A1 (en) 1992-08-12
ZA92729B (en) 1992-11-25
PT100097A (pt) 1993-04-30
GB9102727D0 (en) 1991-03-27
GB2252557A (en) 1992-08-12
IL100793A0 (en) 1992-09-06
WO1992013853A1 (en) 1992-08-20
AU1189392A (en) 1992-09-07
AP9200355A0 (en) 1993-08-03
HUT60489A (en) 1992-09-28
HU9200354D0 (en) 1992-04-28
CA2060825A1 (en) 1992-08-09
GB9202377D0 (en) 1992-03-18

Similar Documents

Publication Publication Date Title
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922252A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
FI915826L (fi) Farmaceutiska aemnen.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
FI914607L (fi) Farmaceutisk blandning i gelform i en dispenserfoerpackning.
FI912952L (fi) Kontrollerbart frigoerande farmaceutiskt preparat.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
DE68911473D1 (de) Arzneimittelformulierungen.
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
FI903382A0 (fi) Topiskt anbringbara farmaceutiska preparat.
FI911738A7 (fi) Anordning foer administrering av pulverformiga medicinska aemnen.
FI921924A0 (fi) Portabel koldioxidmonitor.
FI930737A7 (fi) Asialoglykoproteiiniin sidottu lääkeaine
NO912799L (no) Foradditiver for droevtyggere.
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
FI924456A7 (fi) Lääke
MX9201969A (es) Formulacion de tableta optimizada.
FI922022A0 (fi) Korrugerad tunn metallfolie.
FI911652L (fi) Farmaceutisk beredning av nitroglycering foer perkutan administration.
DZ1559A1 (fr) Compositions pharmaceutiques.
NO911429D0 (no) Stoffbehandling.
DK0581523T3 (da) Injektionssprøjte.
MX9200532A (es) Agente farmaceuticos.